Publications by authors named "D P C Vergouwen"

Scleritis is a severe and painful ophthalmic disorder, in which a pathogenic role for collagen-directed autoimmunity was repeatedly suggested. We evaluated the presence of sclera-specific antibodies in a large cohort of patients with non-infectious scleritis. Therefore, we prospectively collected serum samples from 121 patients with non-infectious scleritis in a multicenter cohort study in the Netherlands.

View Article and Find Full Text PDF

Purpose: To determine the thickness of the conjunctiva, episclera and sclera in healthy individuals using anterior segment optical coherence tomography (AS-OCT).

Methods: We prospectively included 107 healthy individuals of different age groups (18-39 years, 40-54 years, 55-69 years and ≥70 years). For each eye, AS-OCT scans of four quadrants (temporal, nasal, superior and inferior) were acquired.

View Article and Find Full Text PDF

Purpose: Keratoconus is characterized by the progressive thinning of the cornea, which leads to a cone-like appearance of the eye over time. Although conventionally defined as a noninflammatory condition, a number of recent studies have associated keratoconus (KC) with allergic conjunctivitis (AC) based on clinical parameters. This study aimed to consolidate this association by performing a proteomic analysis of tear fluid from patients with keratoconus and/or allergic conjunctivitis.

View Article and Find Full Text PDF
Article Synopsis
  • Scleritis is a serious eye condition causing severe pain and risk of blindness, prompting a study to investigate its biological markers through proteomics in serum and tears.
  • Researchers conducted a multicenter study involving 121 patients with noninfectious scleritis and control groups to analyze inflammatory proteins using advanced assays.
  • Significant findings included 18 proteins that differed notably in scleritis patients, with specific proteins related to neurogenesis and immune response being highlighted as potential biomarkers for understanding the disease.
View Article and Find Full Text PDF

Purpose: To report on an unexpected side effect of Rituximab (RTX), a B-cell targeting monoclonal agent, in a patient with severe sclerouveitis, leading to severe visual loss.

Methods: Observational case report.

Results: A 61-year-old female was treated with RTX for a severe sclerouveitis occurring with granulomatosis with polyangiitis.

View Article and Find Full Text PDF